Calendrier des promotions NeuroPace, Inc.
Calendrier avancé
Graphique simple
À propos de l'entreprise NeuroPace, Inc.
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. The company's RNS system also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip leads and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. plus de détailsParamètres de base
IPO date
2021-04-22
ISIN
US6412881053
Industry
Health Care Equipment & Supplies
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
Grade
Sous-estimation
| Nom | Signification | Grade |
| P/S | 4.08 | 4 |
| P/BV | 40.67 | 1 |
| P/E | 0 | 0 |
Efficacité
| Nom | Signification | Grade |
| ROA | -26.83 | 0 |
| ROE | -189.35 | 0 |
| ROIC | 0 | 0 |
Dividendes
| Nom | Signification | Grade |
| Rendement en dividendes | 0 | 0 |
| DSI | 0 | 0 |
| Croissance moyenne du dividende | 0 | 0 |
Devoir
| Nom | Signification | Grade |
| Debt/EBITDA | -4.42 | 10 |
| Debt/Ratio | 0.7749 | 9 |
| Debt/Equity | 10.81 | 0 |
Impulsion de croissance
| Nom | Signification | Grade |
| Rentabilité Revenue, % | 94.42 | 9 |
| Rentabilité Ebitda, % | 32.59 | 5 |
| Rentabilité EPS, % | -71.24 | 0 |
paper.price.prices
| Prix | Common.min. | Common.max. | Changement | paper.changes_in_industry | paper.changes_in_index | |
| common.calendar.number_days.1 | 12.66 $ | 0 $ | 0 $ | -6.79 % | 0 % | 0 % |
| common.calendar.number_days.7d | 18.13 $ | 0 $ | 0 $ | -34.91 % | 0 % | 0 % |
| common.calendar.number_days.30d | 11.62 $ | 11.8 $ | 18.13 $ | 1.55 % | 0 % | 0 % |
| common.calendar.number_days.90d | 13.48 $ | 10.34 $ | 18.13 $ | -12.46 % | 0 % | 0 % |
| common.calendar.number_days.180d | 10.25 $ | 10.04 $ | 18.13 $ | 15.12 % | 0 % | 0 % |
| common.calendar.number_days.1y | 7.09 $ | 5.9 $ | 18.13 $ | 66.43 % | 0 % | 0 % |
| common.calendar.number_days.3y | 6 $ | 1.29 $ | 18.13 $ | 96.67 % | 0 % | 0 % |
| common.calendar.number_days.5y | 0 $ | 1.29 $ | 26.5 $ | 0 % | 0 % | 0 % |
| common.calendar.number_days.10y | 0 $ | 1.29 $ | 26.5 $ | 0 % | 0 % | 0 % |
| common.calendar.number_days.ytd | 10.64 $ | 10.04 $ | 18.13 $ | 10.9 % | 0 % | 0 % |
Principaux propriétaires
Entreprises similaires
P/E & P/BV
Gestion d'entreprise
| Superviseur | Titre d'emploi | Paiement | Année de naissance |
| Dr. Martha J. Morrell | Chief Medical Officer | 728.68k | 1957 (68 années) |
| Mr. Joel D. Becker | CEO, President & Director | 762k | 1968 (57 années) |
| Ms. Rebecca L. Kuhn | CFO, VP of Finance & Administration, Corporate Secretary and Assistant Secretary | 614.91k | 1961 (64 année) |
| Ms. Kelley Nicholas | Vice President of Sales | N/A | |
| Ms. Leah Akin | Acting General Counsel | N/A | |
| Mr. Dylan St. John | Chief of Operations & Development |
Informations sur l'entreprise
Adresse: United States, Mountain View. CA, 455 North Bernardo Avenue - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.neuropace.com
Site web: https://www.neuropace.com
